Stay updated on BI 1323495 Dose Tolerance & Inflammation Biomarkers Clinical Trial

Sign up to get notified when there's something new on the BI 1323495 Dose Tolerance & Inflammation Biomarkers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BI 1323495 Dose Tolerance & Inflammation Biomarkers Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:46:20.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the number of participants enrolled in a study focusing on the safety and tolerability of a medicine called BI 1323495 in patients with non-cystic fibrosis bronchiectasis.
    Difference
    0.1%
    Check dated 2024-06-06T14:34:04.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for study participants, specifying age, gender, health conditions, and prior treatments required for inclusion. Previously, no information was provided for collaborators and investigators.
    Difference
    39%
    Check dated 2024-05-22T21:30:15.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:36:56.000Z thumbnail image

Stay in the know with updates to BI 1323495 Dose Tolerance & Inflammation Biomarkers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BI 1323495 Dose Tolerance & Inflammation Biomarkers Clinical Trial page.